Purpose Unlimited Inc. Acquires Shares of 28,048 Healthpeak Properties, Inc. $DOC

Purpose Unlimited Inc. acquired a new position in shares of Healthpeak Properties, Inc. (NYSE:DOC) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 28,048 shares of the real estate investment trust’s stock, valued at approximately $451,000.

A number of other institutional investors also recently modified their holdings of DOC. Fiduciary Trust Co increased its position in Healthpeak Properties by 4.9% during the third quarter. Fiduciary Trust Co now owns 13,807 shares of the real estate investment trust’s stock worth $264,000 after acquiring an additional 644 shares during the period. Patton Fund Management Inc. boosted its holdings in Healthpeak Properties by 5.2% in the 4th quarter. Patton Fund Management Inc. now owns 13,002 shares of the real estate investment trust’s stock valued at $209,000 after purchasing an additional 648 shares during the period. Quadrant Capital Group LLC grew its position in shares of Healthpeak Properties by 1.9% during the 3rd quarter. Quadrant Capital Group LLC now owns 37,650 shares of the real estate investment trust’s stock worth $721,000 after purchasing an additional 718 shares in the last quarter. New Mexico Educational Retirement Board grew its position in shares of Healthpeak Properties by 2.5% during the 4th quarter. New Mexico Educational Retirement Board now owns 32,200 shares of the real estate investment trust’s stock worth $518,000 after purchasing an additional 800 shares in the last quarter. Finally, Arjuna Capital increased its holdings in shares of Healthpeak Properties by 5.7% during the fourth quarter. Arjuna Capital now owns 15,606 shares of the real estate investment trust’s stock worth $251,000 after purchasing an additional 838 shares during the period. Institutional investors own 93.57% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on DOC. Weiss Ratings upgraded Healthpeak Properties from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, May 8th. Wall Street Zen upgraded Healthpeak Properties from a “sell” rating to a “hold” rating in a research note on Sunday, May 10th. UBS Group lifted their price objective on Healthpeak Properties from $17.00 to $19.00 and gave the company a “neutral” rating in a report on Wednesday, May 13th. Scotiabank upped their target price on Healthpeak Properties from $19.00 to $21.00 and gave the company a “sector perform” rating in a research report on Wednesday, May 27th. Finally, Robert W. Baird increased their target price on Healthpeak Properties from $19.00 to $21.00 and gave the stock an “outperform” rating in a report on Wednesday, May 13th. Three equities research analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the stock. According to MarketBeat, Healthpeak Properties presently has an average rating of “Hold” and a consensus price target of $19.86.

Healthpeak Properties Stock Performance

Shares of Healthpeak Properties stock opened at $19.56 on Monday. The company has a 50 day moving average of $18.66 and a 200-day moving average of $17.54. Healthpeak Properties, Inc. has a 1-year low of $15.70 and a 1-year high of $20.82. The company has a current ratio of 2.96, a quick ratio of 2.96 and a debt-to-equity ratio of 1.15. The company has a market cap of $13.49 billion, a PE ratio of 61.13, a price-to-earnings-growth ratio of 3.05 and a beta of 1.05.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings data on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.43 by $0.02. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The business had revenue of $752.95 million for the quarter, compared to analysts’ expectations of $694.59 million. During the same period last year, the firm posted $0.46 earnings per share. The firm’s quarterly revenue was up 7.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. As a group, equities research analysts forecast that Healthpeak Properties, Inc. will post 1.75 earnings per share for the current fiscal year.

Healthpeak Properties Dividend Announcement

The firm also recently announced a monthly dividend, which will be paid on Friday, June 26th. Shareholders of record on Monday, June 15th will be issued a $0.1017 dividend. This represents a c) dividend on an annualized basis and a dividend yield of 6.2%. The ex-dividend date of this dividend is Monday, June 15th. Healthpeak Properties’s dividend payout ratio (DPR) is currently 381.25%.

Insider Activity

In other news, insider Scott R. Bohn sold 10,989 shares of Healthpeak Properties stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total value of $213,736.05. Following the transaction, the insider owned 7,636 shares in the company, valued at approximately $148,520.20. This trade represents a 59.00% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.23% of the company’s stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.